𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Osmotic Demyelination Syndrome as a Consequence of Treating Hyperammonemia in a Patient with Ornithine Transcarbamylase Deficiency

✍ Scribed by Cardenas, J. F.; Bodensteiner, J. B.


Book ID
121467389
Publisher
SAGE Publications
Year
2009
Tongue
English
Weight
202 KB
Volume
24
Category
Article
ISSN
0883-0738

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hyperammonemia caused by impaired mitoch
✍ Tateo Kuno; Sumio Miyazaki; Ituro Inoue; Takeyori Saheki πŸ“‚ Article πŸ“… 1990 πŸ› Elsevier Science 🌐 English βš– 423 KB

Late-onset hyperammonemia was observed in a male patient with partial quantitative deficiency of ornithine carbamoyltransferase (OCT). His liver contained 10% of the normal level of OCT, but with normal kinetics. This reduced enzyme activity alone, however, could not explain the hyperammonemia. Ther

Ornithine transcarbamylase (OTC) deficie
✍ Ryszard Slomski; Ingrid Braulke; Claudia Behrend; Elisabeth SchrΓΆder; Jean-Pierr πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 363 KB

A girl with ornithine transcarbamylase (OTC) deficiency was investigated for molecular and cytogenetic abnormalities that might explain this phenotype. Analysis with polymorphic DNA markers indicated that the patient did not inherit paternal alleles of the OTC locus, but that she did inherit the pro

Identification of seven novel missense m
✍ Consuelo Climent; Vicente Rubio πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 32 KB πŸ‘ 1 views

Ornithine transcarbamylase (OTC) deficiency, a X-linked disorder, is the most frequent inborn error of the urea cycle. Point mutations and small deletions/insertions in the OTC gene are responsible for the majority of the cases and have a "private"character with little recurrence. We report on eleve

Cerebral demyelination syndrome in a pat
✍ Diane M. Savarese; Jeffrey Gordon; Thomas W. Smith; N. Scott Litofsky; Robert Li πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 804 KB

## Background: The use of 5-fluorouracil (5-fu) and levamisole in patients with stage iii adenocarcinoma of the colon has now become standard. there have been several reports of a multifocal cerebral demyelination syndrome following 5-fu and levamisole administration. ## Methods: We describe a pa